NSE: KAYA · Wellness
Snapshot
Growth · Profitability · Valuation · Strength · Conviction
Kaya Limited is a specialised provider of dermatological and hair care solutions, operating a chain of clinics across India and the Middle East. The company offers a comprehensive suite of clinical treatments alongside a retail range of skin and hair care products.
The company generates revenue through a hybrid model of clinical service delivery and the direct sale of proprietary skin and hair care products. Distribution is facilitated through its own network of clinics, third-party retail outlets, and its dedicated e-commerce platform.
Growth is expected to be driven by the expansion of its clinical footprint and the strengthening of its omnichannel retail presence. The company continues to focus on addressing rising consumer demand for specialised aesthetic and wellness treatments.
Unlock AI insights, financials, peers and live data on Kaya Ltd. and 5,000+ companies — free.
P/E
-3.7x
Q4 FY26 · consolidated
EV/EBITDA
-35.2x
Q4 FY26 · consolidated
NET PROFIT MARGIN
-49.8%
Q4 FY26 · consolidated
DEBT TO EQUITY
-1.1x
Q4 FY26 · consolidated
| Company | Mkt Cap (Cr) | P/E | EV/EBITDA | Rev Gr YoY | EBITDA Mgn | ROE | ROCE | 1Y Return |
|---|---|---|---|---|---|---|---|---|
Kaya Ltd.KAYA | 391 | -3.70 | -35.20 | — | -6.8% | 67.4% | -62.1% | -43.7% |
Advani Hotels.ADVANIHOTR | 451 | 18.60 | 12.71 | -0.7% | 35.5% | 13.6% | 17.2% | -16.2% |
HLVHLVLTD | 446 | 92.50 | 17.31 | -1.2% | 13.8% | 0.4% | 1.0% | -44.1% |
Speciality Rest.SPECIALITY | 446 | 29.12 | 6.15 | 9.2% | 21.2% | 6.2% | 9.1% | -3.1% |
Espire HospiESPIRE | 387 | 12.35 | 8.12 | 13.1% | 32.5% | 49.6% | 20.7% | -64.7% |
Sinclairs HotelsSINCLAIR | 374 | 42.54 | 17.40 | 10.9% | 37.4% | 7.7% | 10.2% | -21.4% |
As of Q4 FY26
Kaya Ltd.
NSE: KAYA · Wellness
Snapshot
Growth · Profitability · Valuation · Strength · Conviction
Kaya Limited is a specialised provider of dermatological and hair care solutions, operating a chain of clinics across India and the Middle East. The company offers a comprehensive suite of clinical treatments alongside a retail range of skin and hair care products.
The company generates revenue through a hybrid model of clinical service delivery and the direct sale of proprietary skin and hair care products. Distribution is facilitated through its own network of clinics, third-party retail outlets, and its dedicated e-commerce platform.
Growth is expected to be driven by the expansion of its clinical footprint and the strengthening of its omnichannel retail presence. The company continues to focus on addressing rising consumer demand for specialised aesthetic and wellness treatments.
Loading…
Unlock AI insights, financials, peers and live data on Kaya Ltd. and 5,000+ companies — free.
P/E
-3.7x
Q4 FY26 · consolidated
EV/EBITDA
-35.2x
Q4 FY26 · consolidated
NET PROFIT MARGIN
-49.8%
Q4 FY26 · consolidated
DEBT TO EQUITY
-1.1x
Q4 FY26 · consolidated
As of Q4 FY26